Increased NF-κB activation has been previously described as a strong stimulus of inflammation and metabolic impairments in T2D [129], and this study extends the negative effects of hyperglycemia to the brain microvasculature due to NOX1 activation. The gene discussed is NFKB1; the disease is Hyperglycemia.